Dr. Scott M. McGinnis, MD

Dr. McGinnis practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. McGinnis' NPI, 1912932906, was assigned on July 11, 2006. Dr. McGinnis graduated from Baylor College of Medicine in 2002. Dr. McGinnis holds Massachusetts license 229844.

Dr. McGinnis' primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. McGinnis' primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. McGinnis is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. McGinnis to 2 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGinnis practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. McGinnis' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. McGinnis is licensed in Massachusetts.

CMS data shows 532 Medicare services from Dr. McGinnis across 8 procedure codes in 2024, for 229 Medicare patients. Medicare paid $45,144 for them.

CMS counts 229 Medicare patients who saw Dr. McGinnis in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McGinnis' median patient age at 77, with 52% women.

In 2024, Dr. McGinnis wrote 481 Medicare Part D claims for 95 patients. 100% of them were for generic drugs. CMS names the drug for 359 of them, across 13 drugs with 11 or more claims each, at $18,778 in total drug cost. In 2023, CMS named 113 claims across 5 drugs.

Dr. McGinnis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McGinnis as offering telehealth.

Dmand AI links 42 papers to Dr. McGinnis, published from 2010 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Alzheimer Disease, Magnetic Resonance Imaging and tau Proteins. Dr. McGinnis has published most often in J Neuropsychiatry Clin Neurosci. Dr. McGinnis' most frequent co-authors are Bradford Clark Dickerson, MD, Kirk R. Daffner, MD and Seth A. Gale, MD.

Dmand AI links Dr. McGinnis to 2 clinical trials. Conditions studied include Alzheimer Disease, Memory Disorders and Cognitive Dysfunction.

CMS Open Payments shows 2 general payments to Dr. McGinnis from 1 drug or device company in 2024. Consulting fees make up the largest share, 59% of the total. Eisai Inc. paid the most, $8,483.

Dr. McGinnis graduated from Baylor College of Medicine in 2002.